Characteristics of Empagliflozin Initiators

Clinical trial NCT03050619 · COMPLETED

Trial details

NCT number: NCT03050619
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes

Start date: 2016-09-10
Primary completion: 2016-10-14
Enrollment: 31908

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.